AO’s innovation funding recipient Momentum Health achieves FDA clearance for AI-enabled mobile application

Momentum Health—a recipient of the AO’s innovation funding—recently achieved a significant milestone by receiving the US Food and Drug Administration (FDA) clearance for its innovative AI-enabled mobile app, Momentum Spine.

This app, designed for the monitoring of scoliosis, leverages cutting-edge technology to provide a radiation-free tool for the management of this condition. The AO has played a crucial role in supporting this breakthrough via its innovation funding, emphasizing the app's potential to empower patients and streamline healthcare processes.

The collaboration between Momentum Health and the AO underlines a shared commitment to advancing patient care through technological innovation.

Learn about Momentum Health’s major milestone in their press release.

Do you have an innovation you want to bring to life with the AO’s expertise and funding? Applications are open through February 29, 2024.

You might also be interested in: